Mutations of the conserved residues of influenza virus neuraminidase (NA) that are associated with NA inhibitor (NAI) resistance decrease the sialidase activity and/or stability of the NA, thus compromising viral fitness. In fact, clinically derived NAI-resistant variants with different NA mutations have shown different transmissibilities in ferrets (M. L. Herlocher, R. Truscon, S. Elias, H. Yen, N. A. Roberts, S. E. Ohmit, and A. S. Monto, J. Infect. Dis. 190:1627-1630, 2004). Molecular characterization of mutant viruses that have a homogeneous genetic background is required to determine the effect of single mutations at conserved NA residues. We generated recombinant viruses containing either the wild-type NA (RG WT virus) or a single ami...
The therapeutic benefits of the neuraminidase (NA) inhibitor oseltamivir are dampened by the emergen...
Objectives and methods: An influenza B virus plasmid-based rescue system was used to introduce site-...
influenza B virus plasmid-based rescue system was used to introduce site-specific mutations, previou...
Mutations of the conserved residues of influenza virus neuraminidase (NA) that are associated with N...
Neuraminidase inhibitors (NAIs) are antivirals designed to target conserved residues at the neuramin...
The acquisition of neuraminidase (NA) inhibitor resistance by H5N1 influenza viruses has serious cli...
Neuraminidase inhibitors (NAIs) are antivirals designed to target conserved residues at the neuramin...
Effective antiviral drugs are essential for early control of an influenza pandemic. It is therefore ...
Neuraminidase (NA) inhibitors are a class of antivirals designed to target the conserved residues of...
Treatment options for influenza B virus infections are limited to neuraminidase inhibitors (NAIs), w...
Neuraminidase inhibitors (NAI) remain the mainstay therapeutic option against influenza infections. ...
Neuraminidase (NA) inhibitors are one of two classes of antiviral compounds available for the contro...
Epidemics and pandemics of influenza continue to be major global health threats. Control measures ag...
influenza B virus plasmid-based rescue system was used to introduce site-specific mutations, previou...
Epidemics and pandemics of influenza continue to be major global health threats. Control measures ag...
The therapeutic benefits of the neuraminidase (NA) inhibitor oseltamivir are dampened by the emergen...
Objectives and methods: An influenza B virus plasmid-based rescue system was used to introduce site-...
influenza B virus plasmid-based rescue system was used to introduce site-specific mutations, previou...
Mutations of the conserved residues of influenza virus neuraminidase (NA) that are associated with N...
Neuraminidase inhibitors (NAIs) are antivirals designed to target conserved residues at the neuramin...
The acquisition of neuraminidase (NA) inhibitor resistance by H5N1 influenza viruses has serious cli...
Neuraminidase inhibitors (NAIs) are antivirals designed to target conserved residues at the neuramin...
Effective antiviral drugs are essential for early control of an influenza pandemic. It is therefore ...
Neuraminidase (NA) inhibitors are a class of antivirals designed to target the conserved residues of...
Treatment options for influenza B virus infections are limited to neuraminidase inhibitors (NAIs), w...
Neuraminidase inhibitors (NAI) remain the mainstay therapeutic option against influenza infections. ...
Neuraminidase (NA) inhibitors are one of two classes of antiviral compounds available for the contro...
Epidemics and pandemics of influenza continue to be major global health threats. Control measures ag...
influenza B virus plasmid-based rescue system was used to introduce site-specific mutations, previou...
Epidemics and pandemics of influenza continue to be major global health threats. Control measures ag...
The therapeutic benefits of the neuraminidase (NA) inhibitor oseltamivir are dampened by the emergen...
Objectives and methods: An influenza B virus plasmid-based rescue system was used to introduce site-...
influenza B virus plasmid-based rescue system was used to introduce site-specific mutations, previou...